A Multicentre Randomised Clinical Trial of Intravitreal Bevacizumab (Avastin) Versus Intravitreal Dexamethasone (Ozurdex) for Persistent Diabetic Macular Oedema

Trial Profile

A Multicentre Randomised Clinical Trial of Intravitreal Bevacizumab (Avastin) Versus Intravitreal Dexamethasone (Ozurdex) for Persistent Diabetic Macular Oedema

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Oct 2016

At a glance

  • Drugs Bevacizumab (Primary) ; Dexamethasone (Primary)
  • Indications Diabetic macular oedema
  • Focus Therapeutic Use
  • Acronyms BEVORDEX
  • Most Recent Events

    • 02 Jun 2015 Status changed from active, no longer recruiting to completed. as reported by ClinicalTrials.gov.
    • 29 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 22 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top